Cover Image
市場調查報告書

細胞培養的全球市場預測 2023年:生物醫藥品&治療、疫苗生產、診斷、重組蛋白品質、癌症研究、幹細胞技術、藥物篩檢&開發、組織工程&再生醫療

Cell Culture Market by Consumables (Serum free media, FBS, ABS), Equipment {Bioreactor, Supporting Equipment (Centrifuge, Filtration System)}, Application (Biopharmaceutical, Cancer Research), End Users (Pharma, Research) - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 308211
出版日期 內容資訊 英文 248 Pages
訂單完成後即時交付
價格
Back to Top
細胞培養的全球市場預測 2023年:生物醫藥品&治療、疫苗生產、診斷、重組蛋白品質、癌症研究、幹細胞技術、藥物篩檢&開發、組織工程&再生醫療 Cell Culture Market by Consumables (Serum free media, FBS, ABS), Equipment {Bioreactor, Supporting Equipment (Centrifuge, Filtration System)}, Application (Biopharmaceutical, Cancer Research), End Users (Pharma, Research) - Global Forecast to 2023
出版日期: 2018年04月13日 內容資訊: 英文 248 Pages
簡介

全球細胞培養的市場,預計從2018年到2023年以11.4%的年複合成長率 (CAGR) 發展,預計從2018年的153億2,000萬美元,到2023年成長到262億8,000萬美元的規模。該市場的成長,由於法規當局對細胞培養型疫苗的批准數量增加,對單株抗體 (mAb) 的需求增加,單回使用技術偏好的高漲,及先進細胞培養產品的銷售而受到促進。可是,對細胞生物學研究高額的成本及細胞為基礎的研究活動的適當基礎設施的不足,成為抑制該市場成長的主要原因。

本報告提供全球細胞培養的市場相關調查,市場定義和概要,市場成長的影響因素及市場機會分析,各設備、消耗品、用途、終端用戶、地區的主要趨勢與市場規模的變化與預測,競爭環境與市場佔有率,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 細胞培養:市場概要
  • 歐洲的細胞培養容器市場:各類型
  • 細胞培養血清、培養基、試劑市場:各類型
  • 細胞培養市場:各用途
  • 細胞培養市場:各終端用戶市
  • 細胞培養市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題

第6章 細胞培養市場:各產品

  • 簡介
  • 設備
    • 生物反應器
      • 傳統生物反應器
      • 單回使用生物反應器
    • 容器
      • 燒瓶
      • 轉瓶/洛氏瓶
      • 細胞工廠系統/細胞堆棧
      • 培養皿
      • 多孔盤
    • 保存設備
      • 冰箱、冰櫃
      • 低溫存儲系統
    • 支援設備
      • 電池單元計數器
      • 過濾系統
      • 離心機
      • 二氧化碳培養器
      • 高壓釜
      • 顯微鏡
      • 生物安全櫃
      • 其他
  • 消耗品
    • 血清、培養基、試劑
    • 生物反應器配件

第7章 細胞培養市場:各用途

  • 簡介
  • 生物醫藥品、治療用途
    • 疫苗生產
    • 診斷
    • 重組蛋白品質
  • 癌症研究
  • 幹細胞技術
  • 藥物篩檢、開發
  • 組織工程、再生醫療
  • 其他

第8章 細胞培養市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 研究機關

第9章 細胞培養市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他的歐洲
  • 亞洲
  • 其他 (ROW)

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • GE HEALTHCARE
  • LONZA GROUP AG
  • CORNING, INC.
  • BECTON, DICKINSON AND COMPANY
  • EPPENDORF AG
  • HI-MEDIA LABORATORIES
  • SARTORIUS AG
  • PROMOCELL GMBH
  • IRVINE SCIENTIFIC
  • DANAHER
  • INVIVOGEN
  • CELLGENIX
  • MILTENYI BIOTECH

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2561

"The global cell culture market projected to grow at a CAGR of 11.4%."

The global cell culture market is expected to reach USD 26.28 billion by 2023 from USD 15.32 billion in 2018, at a CAGR of 11.4%. Growth in this market is driven by the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining the growth of this market.

"Consumables are expected to grow at the highest CAGR during the forecast period."

Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to register the highest CAGR during the forecast period. The repeated purchase of consumables for various cell culture applications is the major factor supporting the growth of the consumables segment during the forecast period.

"Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period."

Based on end user, the cell culture market is segmented into pharmaceutical and biotechnology companies and research institutes. The pharmaceutical and biotechnology companies segment accounted for the largest market share in 2017 and is projected to register the highest CAGR during the forecast period. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and presence of a large number of pharmaceutical players in this market are driving the cell culture market for this end-user segment.

"Asia to witness the highest growth during the forecast period."

In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in the Asian market is attributed to factors such as favorable regulatory guidelines, lower manufacturing costs, growing presence of market players in emerging economies, and favorable government investments in the life sciences sector.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%; Tier 2 - 46%; Tier 3 - 18%.
  • By Designation: C-level- 29%; D-level- 43%; Others- 28%.
  • By Region: North America-39%; Europe-29%; Asia -20%; Rest of the World- 12%

List of companies profiled in the report:

  • Thermo Fisher Scientific (US)
  • Merck KGaA (Germany)
  • GE Healthcare (US)
  • Lonza (Switzerland)
  • Becton, Dickinson and Company (US)
  • Corning Incorporated (US)
  • Eppendorf AG (Germany)
  • HiMedia Laboratories (India)
  • Sartorius AG (Germany)
  • PromoCell GmbH (Germany)
  • Danaher Corporation (US)
  • Irvine Scientific (US)
  • InvivoGen (US)
  • CellGenix GmbH (Germany)
  • Miltenyi Biotec (Germany)

Research Coverage:

The report provides an overview of the cell culture market. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall cell culture market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATION
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
  • 2.2. SECONDARY DATA
    • 2.2.1. SECONDARY SOURCE
  • 2.3. PRIMARY DATA
    • 2.3.1. KEY DATA FROM PRIMARY SOURCES
    • 2.3.2. KEY INDUSTRY INSIGHTS
  • 2.4. MARKET SIZE ESTIMATION
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL CULTURE: MARKET OVERVIEW
  • 4.2. EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE (2017)
  • 4.3. CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE
  • 4.4. CELL CULTURE MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION)
  • 4.5. CELL CULTURE MARKET, BY END USER, 2018 VS.2023 (USD BILLION)
  • 4.6. GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Growing awareness about the benefits of cell culture-based vaccines
      • 5.2.1.2. Increasing demand for monoclonal antibodies
      • 5.2.1.3. Funding for cell-based research
      • 5.2.1.4. Growing preference for single-use technologies
      • 5.2.1.5. Launch of advanced cell culture products
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. High cost of cell biology research
      • 5.2.2.2. Lack of infrastructure for cell-based research in emerging economies
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Growing demand for 3D cell culture
      • 5.2.3.2. Increased risk of pandemics and communicable diseases
      • 5.2.3.3. Emerging economies
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Survival of new entrants

6. CELL CULTURE MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. EQUIPMENT
    • 6.2.1. BIOREACTORS
      • 6.2.1.1. Conventional bioreactors
      • 6.2.1.2. Single-use bioreactors
    • 6.2.2. VESSELS
      • 6.2.2.1. Flasks
      • 6.2.2.2. Roller/roux bottles
      • 6.2.2.3. Cell factory systems/cell stacks
      • 6.2.2.4. Petri dishes
      • 6.2.2.5. Multiwell plates
    • 6.2.3. STORAGE EQUIPMENT
      • 6.2.3.1. Refrigerators and freezers
      • 6.2.3.2. Cryostorage Systems
    • 6.2.4. SUPPORTING EQUIPMENT
      • 6.2.4.1. Cell counters
      • 6.2.4.2. Filtration systems
      • 6.2.4.3. Centrifuges
      • 6.2.4.4. CO2 Incubators
      • 6.2.4.5. Autoclaves
      • 6.2.4.6. Microscopes
      • 6.2.4.7. Biosafety cabinets
      • 6.2.4.8. Other cell culture supporting equipment
  • 6.3. CONSUMABLES
    • 6.3.1. SERA, MEDIA, AND REAGENTS
      • 6.3.1.1. Sera
        • 6.3.1.1.1. Fetal bovine sera (FBS)
        • 6.3.1.1.2. Adult bovine sera (ABS)
        • 6.3.1.1.3. Other animal sera
      • 6.3.1.2. Media
        • 6.3.1.2.1. Classical media & salts
        • 6.3.1.2.2. Serum-free media
        • 6.3.1.2.3. Specialty media
        • 6.3.1.2.4. Stem cell culture media
      • 6.3.1.3. Cell culture reagents
        • 6.3.1.3.1. Supplements and growth factors
        • 6.3.1.3.2. Buffers and chemicals
        • 6.3.1.3.3. Cell dissociation reagents
        • 6.3.1.3.4. Balanced salt solutions
        • 6.3.1.3.5. Cryoprotective reagents
        • 6.3.1.3.6. Contamination detection kits
        • 6.3.1.3.7. Antibiotics/Antimycotics
        • 6.3.1.3.8. Attachment & matrix factors
        • 6.3.1.3.9. Other cell culture reagents
    • 6.3.2. CELL CULTURE BIOREACTOR ACCESSORIES

7. CELL CULTURE MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS
    • 7.2.1. VACCINE PRODUCTION
    • 7.2.2. DIAGNOSTICS
    • 7.2.3. RECOMBINANT THERAPEUTIC PROTEINS
  • 7.3. CANCER RESEARCH
  • 7.4. STEM CELL TECHNOLOGIES
  • 7.5. DRUG SCREENING & DEVELOPMENT
  • 7.6. TISSUE ENGINEERING & REGENERATIVE MEDICINE
  • 7.7. OTHER APPLICATIONS

8. CELL CULTURE MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.3. RESEARCH INSTITUTES

9. CELL CULTURE MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. UK
    • 9.3.4. ROE
  • 9.4. ASIA
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS, 2017
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2014-2018)
    • 10.3.2. PRODUCT LAUNCHES (2014-2018)
    • 10.3.3. EXPANSIONS (2014-2018)
    • 10.3.4. ACQUISITIONS (2014-2018)

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1. THERMO FISHER SCIENTIFIC
  • 11.2. MERCK KGAA
  • 11.3. GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 11.4. LONZA GROUP AG
  • 11.5. CORNING
  • 11.6. BECTON, DICKINSON AND COMPANY
  • 11.7. EPPENDORF
  • 11.8. HI-MEDIA LABORATORIES
  • 11.9. SARTORIUS AG
  • 11.10. PROMOCELL
  • 11.11. IRVINE SCIENTIFIC
  • 11.12. DANAHER
  • 11.13. INVIVOGEN
  • 11.14. CELLGENIX
  • 11.15. MILTENYI BIOTECH

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATION
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: US GOVERNMENT FUNDING FOR STEM CELL RESEARCH
  • TABLE 2: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 3: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 4: CELL CULTURE EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 7: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 8: CELL CULTURE BIOREACTORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: EUROPE: CELL CULTURE BIOREACTORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 13: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: CELL CULTURE VESSELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 16: CELL CULTURE VESSELS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 19: FLASKS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: ROLLER/ROUX BOTTLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: PETRI DISHES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: MULTIWELL PLATES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 30: CELL CULTURE STORAGE EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: REFRIGERATORS & FREEZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 34: NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 38: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY 2016-2023 (USD MILLION)
  • TABLE 40: EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY 2016-2023 (USD MILLION)
  • TABLE 41: CELL COUNTERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 43: FILTRATION SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 44: NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 45: CENTRIFUGES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 47: CO2 INCUBATORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CO2 INCUBATORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: AUTOCLAVES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 50: NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: MICROSCOPES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: BIOSAFETY CABINETS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 54: NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 55: OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 56: NORTH AMERICA: OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 57: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: CELL CULTURE CONSUMABLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 59: NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 63: NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 64: EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 65: CELL CULTURE SERA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: CELL CULTURE SERA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 67: NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 68: FETAL BOVINE SERA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 69: NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 70: ADULT BOVINE SERA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 71: NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 72: OTHER ANIMAL SERA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 73: NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 74: CELL CULTURE MEDIA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: CELL CULTURE MEDIA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 76: NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 77: CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 78: NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 79: SERUM-FREE MEDIA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 80: NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 81: SPECIALTY MEDIA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 82: NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 83: STEM CELL CULTURE MEDIA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 84: NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 85: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 86: CELL CULTURE REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 87: NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 88: SUPPLEMENTS AND GROWTH FACTORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 89: NORTH AMERICA: SUPPLEMENTS AND GROWTH FACTORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 90: BUFFERS & CHEMICALS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 91: NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 92: CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 93: NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 94: BALANCED SALT SOLUTIONS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 95: NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 96: CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 97: NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 98: CONTAMINATION DETECTION KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 99: NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 100: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 101: ANTIBIOTICS/ANTIBIOTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 102: ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 103: NORTH AMERICA: ATTACHMENT & MATRIX FACTORS, MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 104: OTHER CELL CULTURE REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 105: NORTH AMERICA: OTHER CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 106: CELL CULTURE BIOREACTOR ACCESSORIES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 107: NORTH AMERICA: CELL CULTURE BIOREACTOR ACCESSORIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 108: CELL CULTURE MARKET, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 109: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 111: NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 112: EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 113: VACCINE PRODUCTION MARKET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 114: NORTH AMERICA: VACCINE PRODUCTION MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 115: EUROPE: VACCINE PRODUCTION MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 116: DIAGNOSTICS MARKET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 117: NORTH AMERICA: DIAGNOSTICS MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 118: EUROPE: DIAGNOSTICS MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 119: RECOMBINANT THERAPEUTIC PROTEINS MARKET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 120: NORTH AMERICA: RECOMBINANT THERAPEUTIC PROTEINS MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 121: EUROPE: RECOMBINANT THERAPEUTIC PROTEINS MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122: CELL CULTURE MARKET FOR CANCER RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 123: NORTH AMERICA: CANCER RESEARCH MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 124: EUROPE: CANCER RESEARCH MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 125: CELL CULTURE MARKET FOR STEM CELL TECHNOLOGIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 126: NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL TECHNOLOGIES, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 127: EUROPE: CELL CULTURE MARKET FOR STEM CELL TECHNOLOGIES, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 128: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 129: NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130: EUROPE: DRUG SCREENING & DEVELOPMENT MARKET, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 131: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 132: NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 133: EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 134: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 135: NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136: EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 137: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 138: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 139: NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 140: EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 141: CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 142: NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 143: EUROPE: CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 144: CELL CULTURE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 145: NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 146: NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 147: NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 149: NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 150: NORTH AMERICA: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 151: NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 152: NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 153: NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 154: NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 155: NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 156: NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 157: NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 158: NORTH AMERICA: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 159: NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 160: US: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 161: US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 162: US: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: US: CELL CULTURE VESSELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: US: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 165: US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 166: US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 167: US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 168: US: CELL CULTURE SERA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 169: US: CELL CULTURE MEDIA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 170: US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 171: US: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 172: US: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: US: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 174: CANADA: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 175: CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 176: CANADA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 177: CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 178: CANADA: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 179: CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 180: CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 181: CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 182: CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 183: CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 184: CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 185: CANADA: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 186: CANADA: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 187: CANADA: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 188: EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 189: EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 190: EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 191: EUROPE: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 192: EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 193: EUROPE: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 194: EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 195: EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 196: EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 197: EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 198: EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 199: EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 200: EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 201: EUROPE: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 202: EUROPE: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 203: GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 204: GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 205: GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 206: GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 207: GERMANY: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 208: GERMANY: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 209: FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 210: FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 211: FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 212: FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 213: FRANCE: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 214: FRANCE: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 215: UK: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 216: UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 217: UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 218: UK: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 219: UK: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 220: UK: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 221: ROE: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 222: ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 223: ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 224: ROE: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 225: ROE: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 226: ROE: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 227: ASIA: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 228: ASIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 229: ASIA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 230: ASIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 231: ASIA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 232: ASIA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 233: ASIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 234: ASIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 235: ASIA: CELL CULTURE SERA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 236: ASIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 237: ASIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 238: ASIA: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 239: ASIA: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 240: ASIA: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 241: ROW: CELL CULTURE MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 242: ROW: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 243: ROW: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 244: ROW: CELL CULTURE VESSELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 245: ROW: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 246: ROW: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 247: ROW: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 248: ROW: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 249: ROW: CELL CULTURE SERA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 250: ROW: CELL CULTURE MEDIA MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 251: ROW: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 252: ROW: CELL CULTURE MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 253: ROW: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 254: ROW: CELL CULTURE MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 255: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
  • TABLE 256: EXCHANGE RATES (USED FOR THE CONVERSION OF CHF TO USD)
  • TABLE 257: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
  • TABLE 258: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)

LIST OF FIGURES

  • FIGURE 1: CELL CULTURE MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CELL CULTURE MARKET, BY PRODUCT, 2018 VS. 2023 (USD BILLION)
  • FIGURE 8: CELL CULTURE MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION)
  • FIGURE 9: CELL CULTURE MARKET, BY END USER: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET
  • FIGURE 11: CELL CULTURE MARKET TO WITNESS DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 12: ROLLER/ROUX BOTTLES COMMANDED THE LARGEST SHARE OF THE EUROPEAN CELL CULTURE VESSELS MARKET IN 2017
  • FIGURE 13: CELL CULTURE MEDIA TO REGISTER THE HIGHEST GROWTH RATE BETWEEN 2018 & 2023
  • FIGURE 14: BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS WILL CONTINUE TO DOMINATE THE CELL CULTURE MARKET IN 2023
  • FIGURE 15: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: CONSUMABLES SEGMENT TO DOMINATE THE CELL CULTURE PRODUCTS MARKET IN 2018
  • FIGURE 19: BIOPHARMACEUTICALS/THERAPEUTIC APPLICATIONS SEGMENT TO DOMINATE CELL CULTURE MARKET DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 20: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE CELL CULTURE MARKET IN 2023
  • FIGURE 21: NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
  • FIGURE 22: EUROPE: CELL CULTURE MARKET SNAPSHOT (2018)
  • FIGURE 23: ASIA: CELL CULTURE MARKET SNAPSHOT
  • FIGURE 24: REST OF THE WORLD (ROW): CELL CULTURE MARKET SNAPSHOT
  • FIGURE 25: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2018
  • FIGURE 26: MARKET EVOLUTION FRAMEWORK
  • FIGURE 27: GLOBAL CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 28: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC
  • FIGURE 29: COMPANY SNAPSHOT: MERCK KGAA
  • FIGURE 30: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • FIGURE 31: LONZA GROUP AG: COMPANY SNAPSHOT
  • FIGURE 32: CORNING: COMPANY SNAPSHOT
  • FIGURE 33: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 34: EPPENDORF: COMPANY SNAPSHOT
  • FIGURE 35: SARTORIUS AG: COMPANY SNAPSHOT
  • FIGURE 36: COMPANY SNAPSHOT: DANAHER
Back to Top